Acoustic interfaces in blood and tissue

Acoustic interfaces in blood and tissue represent the biophysical boundaries between distinct biological compartments, such as the blood-endothelium interface or the transition between different organ parenchymas. These interfaces are defined by differences in acoustic impedance, which dictate how ultrasound energy is reflected or scattered during medical imaging procedures (NIH, 2023). Unlike traditional therapeutic targets such as receptors or enzymes, acoustic interfaces are physical phenomena rather than molecular entities. They serve as the functional environment for ultrasound contrast agents, including lipid-stabilized gas microbubbles, which are administered to enhance the acoustic mismatch and improve the visualization of vascularity and tissue perfusion (PubMed, 2021). While these interfaces are critical for diagnostic and certain therapeutic ultrasound applications, such as blood-brain barrier disruption, they do not possess a biochemical mechanism of action or a specific molecular classification. Therefore, they are not considered druggable targets in the context of molecular pharmacology.

Other names

Acoustic impedance boundariesTissue-blood interfacesAcoustic boundariesImpedance mismatch zones

Enhancement of acoustic impedance mismatch at tissue-blood boundaries to increase ultrasound backscatter and improve diagnostic visualization (StatPearls, 2023).